Condition
Pathological Response clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Pathological Response clinical trials that are recruiting, at sites in 2 countries (most in Turkey (Türkiye) (1), China (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Circulating microRNA changes to predict neoadjuvant chemotherapy response in breast cancer.
This will test whether changes in blood microRNA levels before and after chemotherapy can help predict who will have a strong tumor response to neoadjuvant chemotherapy for breast cancer.
-
Combination therapy for high-risk acral melanoma before surgery
This study is testing a new combination of treatments before surgery to see if it can help people with high-risk acral melanoma have better outcomes.
Related topics
Quick answers
How many Pathological Response clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Turkey (Türkiye) (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.